The mitral valve disease global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Mitral Valve Disease Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size -
The
mitral valve disease market size has grown strongly in recent years. It
will grow from $2.75 billion in 2023 to $3 billion in 2024 at a compound
annual growth rate (CAGR) of 9.1%. The growth in the historic period
can be attributed to patient education initiatives, adequate
reimbursement policies and insurance coverage, growing healthcare
expenditure, rising awareness and screening efforts, and expanding
market presence.
The mitral valve disease market size is expected to see strong growth in the next few years. It will grow to $4.32 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growing prevalence of mitral valve disease, increasing adoption for minimally invasive techniques, soaring innovations in heart valve surgery, rise venture capital investments, and rising interest of manufacturers. Major trends in the forecast period include technological advancements, advancements in transcatheter technologies, and increasing technological advancements in surgical procedures.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report
Scope Of Mitral Valve Disease Market
The Business Research Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Mitral Valve Disease Market Overview
Market Drivers -
The
increasing prevalence of vascular heart diseases is expected to propel
the growth of mitral valve disease market going forward. Vascular heart
diseases encompass a group of conditions affecting the blood vessels
supplying the heart or within the heart itself. A complex interplay of
lifestyle choices, demographic changes, medical conditions,
environmental factors, and genetic variables drives the increasing cases
of vascular heart diseases. Vascular heart diseases, such as ischemic
heart disease and hypertension, can indirectly cause mitral valve
disease by compromising the heart's structure and function, leading to
conditions that affect the mitral valve. For instance, in December 2023,
according to data from the Australian Bureau of Statistics 2020-21
National Health Survey conducted by the Australian Institute of Health
and Welfare, an Australia-based government agency, an estimated 571,000
adults aged 18 and over in Australia were living with coronary heart
disease (CHD), comprising 2.9% of the adult population. Moreover, the
prevalence of CHD rises significantly with age, impacting approximately
11% of adults aged 75 and above. Therefore, the increasing prevalence of
vascular heart diseases is driving the mitral valve disease market.
Market Trends -
Major
companies operating in the mitral valve disease market are developing
stented tissue valves to address the growing demand for minimally
invasive treatment options. Stented tissue valves are designed to
provide durable and reliable performance, offering patients an
alternative to traditional surgical interventions. For instance, in
September 2021, Abbott Laboratories, a US-based medical devices and
healthcare company, received approval from the FDA for Epic Plus and
Epic Plus Supra stented tissue valves to treat individuals with aortic
or mitral valve disease. These advanced devices are based on Abbott's
trusted Epic surgical valve platform and anti-calification technology.
Additionally, both valves feature a FlexFit polymer stent that can
withstand approximately 8 atm pressure during balloon valvuloplasty
procedures, a unique pericardial shield to prevent abrasion risk, and a
flexible cuff to mitigate paravalvular leak (PVL) and fit patient
anatomy.
The mitral valve disease market covered in this report is segmented –
1)
By Treatment Type: Mitral Valve Repair, Mitral Valve Replacement,
Cardiac Resynchronization Therapy, Mitral Valve Therapeutics
2) By Indication: Mitral Valve Stenosis, Mitral Valve Prolapse, Mitral Valve Regurgitation
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users
Get an inside scoop of the mitral valve disease market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp
Regional Insights -
Europe
was the largest region in the mitral valve disease market in 2023.
Asia-Pacific is expected to be the fastest-growing region in the
forecast period. The regions covered in the mitral valve disease market
report are Asia-Pacific, Western Europe, Eastern Europe, North America,
South America, Middle East, Africa.
Key Companies -
Major
companies operating in the mitral valve disease market are Pfizer Inc.,
Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston
Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc.,
Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve
Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda,
CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve
LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro
International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter
Technologies GmbH
Table of Contents
1. Executive Summary
2. Mitral Valve Disease Market Report Structure
3. Mitral Valve Disease Market Trends And Strategies
4. Mitral Valve Disease Market – Macro Economic Scenario
5. Mitral Valve Disease Market Size And Growth
…..
27. Mitral Valve Disease Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment